statistiche ricercatore

statistiche per MEOLA, GIOVANNI

Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9304
NA - Nord America 6293
AS - Asia 2684
SA - Sud America 228
OC - Oceania 34
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 18559
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6142
GB - Regno Unito 4221
IT - Italia 2286
CN - Cina 1495
DE - Germania 935
TR - Turchia 495
KR - Corea 421
EU - Europa 304
NL - Olanda 299
RU - Federazione Russa 274
FR - Francia 265
FI - Finlandia 262
UA - Ucraina 258
CO - Colombia 159
SE - Svezia 118
CA - Canada 111
IN - India 100
GR - Grecia 87
JP - Giappone 83
PL - Polonia 71
BR - Brasile 47
ES - Italia 41
DK - Danimarca 36
MX - Messico 32
AU - Australia 27
CH - Svizzera 27
BE - Belgio 22
PT - Portogallo 20
HK - Hong Kong 18
MY - Malesia 16
RO - Romania 16
TW - Taiwan 14
RS - Serbia 13
CZ - Repubblica Ceca 10
NO - Norvegia 10
ID - Indonesia 9
AR - Argentina 8
HU - Ungheria 7
IL - Israele 7
IE - Irlanda 6
NZ - Nuova Zelanda 6
CL - Cile 5
EG - Egitto 5
IR - Iran 5
VE - Venezuela 5
BG - Bulgaria 4
CR - Costa Rica 4
HR - Croazia 4
PH - Filippine 4
VN - Vietnam 4
AL - Albania 3
BD - Bangladesh 3
LT - Lituania 3
TH - Thailandia 3
A1 - ???statistics.table.value.countryCode.A1??? 2
AE - Emirati Arabi Uniti 2
AT - Austria 2
KZ - Kazakistan 2
PE - Perù 2
TN - Tunisia 2
AP - ???statistics.table.value.countryCode.AP??? 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
GM - Gambi 1
HN - Honduras 1
IQ - Iraq 1
KY - Cayman, isole 1
MA - Marocco 1
MD - Moldavia 1
OM - Oman 1
PG - Papua Nuova Guinea 1
PY - Paraguay 1
RE - Reunion 1
SG - Singapore 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
ZA - Sudafrica 1
Totale 18862
Salva come PNG Salva come JPEG
Città #
Southend 3830
Seattle 904
Milan 601
Fairfield 468
Wilmington 453
Beijing 406
Dearborn 376
Jacksonville 325
Woodbridge 324
Mountain View 321
Redmond 301
Ashburn 245
Nanjing 238
Houston 236
Somerville 223
Cambridge 203
Serra 201
Sakarya 190
Ann Arbor 186
Redwood City 166
Bogotá 154
Pisa 99
Hamburg 93
Rome 85
Shenyang 83
Athens 82
Jinan 82
Nanchang 76
Sunnyvale 68
Warsaw 55
Hebei 53
Guangzhou 50
Changsha 49
Bitonto 42
Ottawa 41
Berlin 40
Phoenix 40
Tianjin 38
Odernheim 35
Jiaxing 33
Seoul 30
Turin 30
Los Angeles 29
Shanghai 28
Bologna 25
Duncan 25
Kunming 25
Kiez 24
Hangzhou 23
Cornate D'adda 22
Hefei 22
Cologno Al Serio 21
Ningbo 21
Lanzhou 20
Silver Spring 20
London 19
Nijmegen 19
Tokyo 19
Como 18
New York 18
Verona 18
Zhengzhou 18
Geisenheim 16
Taizhou 16
Chicago 14
Fremont 14
Haikou 13
Helsinki 13
Mexico 13
Philadelphia 13
Rochester 13
Scranton 13
Atlanta 12
Auburn Hills 12
Belgrade 12
Conshohocken 12
Detroit 12
Nürnberg 12
Porto 12
Taipei 12
Taiyuan 12
Kuala Lumpur 11
Napoli 11
Changchun 10
Harbin 10
Padova 10
Santa Clara 10
Utrecht 10
Barcelona 9
Bari 9
Florence 9
Messina 9
Paris 9
Ahnsen 8
Central District 8
Chengdu 8
Gainesville 8
Kwai Chung 8
Margão 8
Saint Petersburg 8
Totale 12408
Salva come PNG Salva come JPEG
Nome #
Atipica presentazione di sclerosi multipla alla RMN : un caso di difficile diagnosi differenziale 375
The progression of Muscular Impairment Rating Scale (MIRS) and the development of cardiac conduction abnormalities in DM1 366
Cerebral involvement in myotonic dystrophies 268
Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2 266
La canalopatia del cloro : diagnosi clinica differenziale 263
Electromechanical delay components during skeletal muscle contraction and relaxation in patients with myotonic dystrophy type 1 252
Andersen's syndrome : a distinct periodic paralysis 241
Treatment for periodic paralysis 239
Cognitive impairment in adult myotonic dystrophies : a longitudinal study 235
Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2 205
Increased visceral adipose tissue rather than BMI as a risk factor for dementia 180
Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy 179
Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion 169
DM1, DM2 e paralisi periodiche : diagnosi e terapia 167
Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency 161
Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy 160
Tolerability and safety of mexiletine in patients with myotonia dystrophy type 1 over time 152
Concurrence of facioscapulohumeral muscular dystrophy and myasthenia gravis 150
Deregulated MicroRNAs in Myotonic Dystrophy Type 2 149
Therapy in myotonic disorders and in muscle channelopathies 140
Persistent autobiographical amnesia: a case report 138
Long-term follow-up free of ventricular fibrillation recurrence after resuscitated cardiac arrest in a myotonic dystrophy type 1 patient 123
Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2 121
Migraine and patent foramen ovale: improvement after transcatheteral closure 121
Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 120
The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel 120
Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2 118
Oculopharyngeal muscular dystrophy in Italy. 117
A newly-described myotonic disorder (proximal myotonic myopathy--PROMM): personal experience and review of the literature 114
Mutation in the S4 segment of the adult skeletal sodium channel gene in an Italian paramyotonia congenita (PC) family 113
Tibialis anterior muscle needle biopsy and sensitive biomolecular methods : a useful tool in myotonic dystrophy type 1 113
"I know that you know that I know" : Neural substrates associated with social cognition deficits in DM1 patients 113
Studio longitudinale del coinvolgimento muscolare e cardiaco nella Distrofia Miotonica di tipo 1 (DM1) e di tipo 2 (DM2) 106
Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction 104
A family with an unusual myotonic and myopathic phenotype and no CTG expansion (proximal myotonic myopathy syndrome): a challenge for future molecular studies 102
Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect 101
Neuropsychological and psychological functioning aspects in myotonic dystrophy type 1 patients in Italy 101
Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis 100
Alterazioni proteine tau liquorali e quoziente intellettivo (QI) nelle Distrofie Miotonichew di tipo 1 (DM1) e di tipo 2 (DM2). 100
Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism 100
Eight novel mutations in SPG4 gene in a large sample of patients with hereditary spastic paraplegia 98
RNA transcription and maturation in skeletal muscle cells are similarly impaired in myotonic dystrophy and sarcopenia : the ultrastructural evidence 98
Bimodal administration of entacapone in Parkinson's disease patients improves motor control 97
Miotonie e canalopatie 96
Status update and interim results from the Asymptomatic Carotid Surgery Trial-2 (ACST-2) 95
New mutations in SCN4A and their biophysical properties 94
Unusual diagnostic and management problems in neuromuscular disease : Gitelman Syndrome 93
Computerized tomography and magnetic resonance muscle imaging in Miyoshi's myopathy 92
Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle 92
Electrophysiology study protocol of arrhythmias in myotonic dystrophy type 1 and type 2 91
Lezioni di Traumatologia 91
RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy type 1 91
Cerebrospinal fluid (CSF) tau and amyloid beta42 (A beta 42) protein abnormalities correlate with executive dysfunction in myotonic dystrophy type 1 (DM1) and type 2 (DM2) 91
Stable hybrid myotubes: a new model for studying re-expression of enzymatic activities in vitro 90
Human skeletal muscle sodium channelopathies 88
Amyotrophic lateral sclerosis presenting during pregnancy : report of clinical and genetic features of three cases 87
Endocrine alterations in myotonic dystrophy type 1 and type 2 : correlation with markers of muscle fiber atrophy 87
Pathogenic role of ribonuclear inclusions in myotonic dystrophy type 2: myth or reality? 87
Apoptosis induced by proteasome inhibition in human myoblast cultures 86
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with Nab 86
Long-term effects of mexiletine on myotonia and on the cardiac conduction system of patients with myotonic dystrophy type 1 86
Treatment for periodic paralysis (Protocol for a Cochcrane Review) 85
Quantitative myotonia assessment: an experimental protocol 85
Early onset, non fluctuating spinocerebellar ataxia and a novel missense mutation in CACNA1A gene 84
Abnormalities of proliferative and differentiative properties in DM1 and DM2 senescence myoblasts -in vitro- 84
Reduction of toxic RNAs in myotonic dystrophies type 1 and type 2 by the RNA helicase p68/DDX5 84
Myotonic dystrophies : state of the art of new therapeutic developments for the CNS 84
Proteome profile in Myotonic Dystrophy type 2 myotubes reveals dysfunction in protein processing and mitochondrial pathways 83
Mexiletine Improves Symptoms and Signs of Myotonia in Non-dystrophic Myotonia 83
Gene expression analysis in Myotonic Dystrophy : indications for a common molecular pathogenic pathway in DM1 and DM2 82
La qualità di vita nelle canalopatie scheletriche: miopatie benigne? 80
Muscle surface mechanical and electrical activities in myotonic dystrophy 80
Cognitive decline in Myotonic dystrophy type 1 (DM1) 80
Myotonia congenita : novel mutations in CLCN1 gene and functional characterizations in Italian patients 80
Brain Connectomics' Modification to Clarify Motor and Nonmotor Features of Myotonic Dystrophy Type 1 80
Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1(DM-1) and in proximal myotonic myopathy (PROMM/DM-2) 79
Redefining clinical phenotype in a large color of Italian non-dystrophic myotonic patients. 78
Myotonic dystrophy type 2 and related myotonic disorders 78
The primary periodic paralyses: diagnosis, pathogenesis and treatment 78
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases 78
Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies 78
The Lombardia Stroke Unit Registry : 1 year experience of a web-based hospital stroke registry - SUN Lombardia 77
Health-related quality of life in myotonic dystrophy type 1 (DM1) and type 2 (DM2) : correlations with indexes of cognitive and behavioral abnormalities 77
Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis 77
Responsabile di Unità Locale di Progetto speciale COFIN-PRIN "Distrofia miotonica di tipo 1 e 2: dalla patogenesi allo sviluppo di protocolli di terapia genica innovativi" 77
Advanced microscopic and histochemical techniques : diagnostic tools in the molecular era of myology 77
Studi di proteomica funzionale in miotubi di pazienti affetti da Distrofia Miotonica di tipo 2 evidenziano alterazioni nelle proteine mitocondriali e nelle proteine coinvolte nel processo di degradazione proteica 76
Dysregulated expression of micrornas in myotonic dystrophy type 1 76
A clinical, genetic and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia 76
Systematic review and meta-analysis of currently available clinical evidence on migraine and patent foramen ovale percutaneous closure: Much ado about nothing? 74
Electromechanical delay components during skeletal muscle contraction and relaxation : novel physiological insights and possible application in Myotonic Dystrophies 74
Proximal myotonic dystrophy mimicking progressive muscular atrophy 74
Survival of patients with Amyotrophic Lateral Sclerosis in a population-based registry 74
Muscle biopsy and cell cultures: potential diagnostic tools in hereditary skeletal muscle channelopathies 73
Gonadal failure is associated with visceral adiposity in myotonic dystrophies 73
Acetazolamide prevents vacuolar myopathy in skeletal muascle of K+ -depleted rats 73
Myotonia permanens with neonatal onset associated with a p.Gly1306Glu mutation in the SCN4A gene. 72
[Expression of a defect in the respiratory chain in cultured human cells] 72
MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosis 72
Novel CLCN1 gene mutation associated with myotonia congenita in Italian patients. 71
Totale 11516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20022
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2015/2016101 0000 00 1421 16261410
2016/20172307 4528151469 2137 5574 11995908152
2017/20183138 311235185519 184375 214147 228216416108
2018/20193790 916310254213 74406 414148 264222248321
2019/20204038 452191187332 304513 491264 502496175131
2020/20211791 126281254175 375264 3160 0000
Totale 20022
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2021